Home › Funds › HighMark Wealth Management LLC › HCAT
HighMark Wealth Management LLC position in HCAT
HEALTH CATALYST INC · Information Technology
HighMark Wealth Management LLC reported holding 871,082 shares of HCAT (HEALTH CATALYST INC) in its Q2 2026 13F filing — a position valued at US$1.7M, representing 0.58% of its reported portfolio and ranking #28 among its reported holdings. HighMark Wealth Management LLC has disclosed HCAT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How HighMark Wealth Management LLC's HCAT position evolved
HighMark Wealth Management LLC first disclosed a stake in HCAT in Q3 2023 at 1,250 shares (US$13K). The position peaked in Q4 2025 at 741,482 shares, worth US$1.8M. Across 12 filings, HighMark Wealth Management LLC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 871,082 shares valued at US$1.7M — a reduction of -32,000 shares quarter over quarter.. Notable position changes include a 13080% increase in Q2 2025 (shares fell 24% over the following quarter), a 88% increase in Q3 2025 (shares fell 16% over the following quarter), a 139% increase in Q4 2025 (shares fell 47% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.25K | $12.65K | New |
| Q4 2023 | 1.25K | $11.57K | Hold |
| Q1 2024 | 1.25K | $9.41K | Hold |
| Q2 2024 | 1.25K | $7.99K | Hold |
| Q3 2024 | 1.25K | $10.18K | Hold |
| Q4 2024 | 1.25K | $8.84K | Hold |
| Q1 2025 | 1.25K | $5.66K | Hold |
| Q2 2025 | 164.75K | $621.11K | Add |
| Q3 2025 | 310.28K | $884.30K | Add |
| Q4 2025 | 741.48K | $1.77M | Add |
| Q1 2026 | 903.08K | $1.13M | Add |
| Q2 2026 | 871.08K | $1.73M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HCAT and 13F data
HCAT (HEALTH CATALYST INC) is a Information Technology company. 8 other funds we track also report a position in HCAT — the largest reported positions include First Light Asset Management, LLC (US$25.5M), CDC Financial, Inc. (US$14.1M), Palogic Value Management, L.P. (US$9.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HCAT
- First Light Asset Management, LLC 12.81M sh · $25.49M · Q2 2026
- CDC Financial, Inc. 7.09M sh · $14.11M · Q2 2026
- Palogic Value Management, L.P. 4.92M sh · $9.80M · Q2 2026
- Nepsis Inc. 2.99M sh · $5.17M · Q3 2026
More on HighMark Wealth Management LLC
FAQ
How long has HighMark Wealth Management LLC held HCAT?
HighMark Wealth Management LLC has disclosed HCAT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is HighMark Wealth Management LLC's current position in HCAT?
As of Q2 2026, HighMark Wealth Management LLC holds 871.08K shares of HCAT (HEALTH CATALYST INC), valued at $1.73M, representing 0.58% of its reported portfolio and ranking #28.
Has HighMark Wealth Management LLC been buying or selling HCAT?
In the latest 13F filing (Q2 2026), HighMark Wealth Management LLC reduced its position in HCAT. The position peaked in Q4 2025 at 741.48K shares.
Which other funds hold HCAT?
Other major institutional holders of HCAT include First Light Asset Management, LLC, CDC Financial, Inc., Palogic Value Management, L.P., among 8 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.